Association of lower urinary tract symptoms and the metabolic syndrome: Results from the boston area community health survey

Journal of Urology

Volumn 189, Issue 1 SUPPL, 2013, Pages

  Kupelian, Varant ^a   McVary, Kevin T ^b   Kaplan, Steven A ^c   Hall, Susan A ^a   Link, Carol L ^a   Aiyer, Lalitha Padmanabhan ^d   Mollon, Patrick ^e   Tamimi, Nihad ^d   Rosen, Raymond C ^a   McKinlay, John B ^a  

^a NEW ENGLAND RESEARCH INSTITUTES   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d PFIZER INC   (United States)

^e PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

epidemiology; metabolic syndrome X; signs and symptoms; urinary tract

Indexed keywords

ADULT; AGED; BLOOD SAMPLING; FEMALE; HEALTH SURVEY; HUMAN; IMPAIRED BLADDER EMPTYING; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICTURITION; NOCTURIA; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 84870931873     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.11.026     Document Type: Article

References (37)

1. M.P. Fitzgerald, C.L. Link, H.J. Litman Beyond the lower urinary tract: the association of urologic and sexual symptoms with common illnesses Eur Urol 52 2007 407
2. M.A. Joseph, S.D. Harlow, J.T. Wei Risk factors for lower urinary tract symptoms in a population-based sample of African-American men Am J Epidemiol 157 2003 906
3. M.C. Michel, L. Mehlburger, H. Schumacher Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia J Urol 163 2000 1725
4. S. Rohrmann, E. Smit, E. Giovannucci Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III) Int J Obes (Lond) 29 2005 310
5. E. Giovannucci, E.B. Rimm, C.G. Chute Obesity and benign prostatic hyperplasia Am J Epidemiol 140 1994 989
6. J. Hammarsten, B. Hogstedt, N. Holthuis Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia Prostate Cancer Prostatic Dis 1 1998 157
7. J.K. Parsons, H.B. Carter, A.W. Partin Metabolic factors associated with benign prostatic hyperplasia J Clin Endocrinol Metab 91 2006 2562
8. S. Rohrmann, E. Smit, E. Giovannucci Associations of obesity with lower urinary tract symptoms and noncancer prostate surgery in the Third National Health and Nutrition Examination Survey Am J Epidemiol 159 2004 390
9. J.P. Burke, T. Rhodes, D.J. Jacobson Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia Am J Epidemiol 164 2006 41
10. J.B. Meigs, B. Mohr, M.J. Barry Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men J Clin Epidemiol 54 2001 935
11. R.C. Rosen, F. Giuliano, C.C. Carson Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) Eur Urol 47 2005 824
12. E.A. Platz, I. Kawachi, E.B. Rimm Physical activity and benign prostatic hyperplasia Arch Intern Med 158 1998 2349
13. E.A. Platz, E.B. Rimm, I. Kawachi Alcohol consumption, cigarette smoking, and risk of benign prostatic hyperplasia Am J Epidemiol 149 1999 106
14. S. Rohrmann, C.J. Crespo, J.R. Weber Association of cigarette smoking, alcohol consumption and physical activity with lower urinary tract symptoms in older American men: findings from the third National Health And Nutrition Examination Survey BJU Int 96 2005 77
15. J. Hammarsten, B. Hogstedt Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia Blood Press 8 1999 29
16. J. Hammarsten, B. Hogstedt Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia Eur Urol 39 2001 151
17. J.B. McKinlay, C.L. Link Measuring the urologic iceberg: design and implementation of the Boston Area Community Health (BACH) Survey Eur Urol 52 2007 389
18. M.J. Barry, F.J. Fowler Jr, M.P. O'Leary The American Urological Association symptom index for benign prostatic hyperplasia The Measurement Committee of the American Urological Association J Urol 148 1992 1549
19. X. Badia, M. Garcia-Losa, R. Dal-Re Validation of a harmonized Spanish version of the IPSS: evidence of equivalence with the original American scale International Prostate Symptom Score Urology 52 1998 614
20. R.S. Epstein, P.A. Deverka, C.G. Chute Validation of a new quality of life questionnaire for benign prostatic hyperplasia J Clin Epidemiol 45 1992 1431
21. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486
22. V. Kupelian, R. Shabsigh, A.B. Araujo Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts Male Aging Study J Urol 176 2006 222
23. R.A. Washburn, K.W. Smith, A.M. Jette The Physical Activity Scale for the Elderly (PASE): development and evaluation J Clin Epidemiol 46 1993 153
24. L.W. Green Manual for scoring socioeconomic status for research on health behavior Public Health Rep 85 1970 815
25. J.L. Schafer Analysis of Incomplete Multivariate Data 1997 Chapman and Hall London
26. E.S. Ford, W.H. Giles, A.H. Mokdad Increasing prevalence of the metabolic syndrome among U.S. adults Diabetes Care 27 2004 2444
27. P. Boyle, C. Robertson, C. Mazzetta The prevalence of lower urinary tract symptoms in men and women in four centres The UrEpik study BJU Int 92 2003 409
28. C.L. Link, J.B. McKinlay Does America's expanding waistline increase the likelihood of urologic symptoms? Results from the Boston Area Community Health (BACH) study J Urol 179 suppl 2008 141 abstract 398
29. S. Cellek, J. Rodrigo, E. Lobos Selective nitrergic neurodegeneration in diabetes mellitus - a nitric oxide-dependent phenomenon Br J Pharmacol 128 1999 1804
30. S. Kasturi, S. Russell, K.T. McVary Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia Curr Urol Rep 7 2006 288
31. K.T. McVary, W. Monnig, J.L. Camps Jr Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized double-blind trial J Urol 177 2007 1071
32. K.T. McVary, C.G. Roehrborn, J.C. Kaminetsky Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia J Urol 177 2007 1401
33. A. Ponholzer, S. Madersbacher Lower urinary tract symptoms and erectile dysfunction; links for diagnosis, management and treatment Int J Impot Res 19 2007 544
34. O.Z. Shenfeld, K.S. Meir, V. Yutkin Do atherosclerosis and chronic bladder ischemia really play a role in detrusor dysfunction of old age? Urology 65 2005 181
35. J.S. Brown, H. Wessells, M.B. Chancellor Urologic complications of diabetes Diabetes Care 28 2005 177
36. P. Starer, L. Libow Cystometric evaluation of bladder dysfunction in elderly diabetic patients Arch Intern Med 150 1990 810
37. T. Ueda, N. Yoshimura, O. Yoshida Diabetic cystopathy: relationship to autonomic neuropathy detected by sympathetic skin response J Urol 157 1997 580